35 results
253G2
IGXT
IntelGenx Technologies Corp.
20 Feb 24
Offering circular supplement
2:07pm
VersaFilm™ technology is intended for indications requiring rapid onset of action, such as migraine, opioid dependence, chronic pain, motion sickness
424B5
ircd7 3vucfv8tt
18 Oct 18
Prospectus supplement for primary offering
9:48pm
424B5
1qmgbvw 6sy
17 Oct 18
Prospectus supplement for primary offering
4:17pm
S-3/A
tiqr2zhbqm2wcup6tchn
4 Oct 18
Shelf registration (amended)
5:28pm
S-3
dn61yv1say9d6u1l3z
24 Sep 18
Shelf registration
1:59pm